These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9774759)

  • 1. Breast cancer risk among women under 55 years of age by joint effects of usage of oral contraceptives and hormone replacement therapy.
    Brinton LA; Brogan DR; Coates RJ; Swanson CA; Potischman N; Stanford JL
    Menopause; 1998; 5(3):145-51. PubMed ID: 9774759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer risk among women under 55 years of age by joint effects of usage of oral contraceptives and hormone replacement therapy.
    Brinton LA; Brogan DR; Coates RJ; Swanson CA; Potischman N; Stanford JL
    Menopause; 2018 Nov; 25(11):1195-1200. PubMed ID: 30358713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral contraceptives and breast cancer.
    Brinton LA; Hoover R; Szklo M; Fraumeni JF
    Int J Epidemiol; 1982 Dec; 11(4):316-22. PubMed ID: 7152784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex steroid hormones and breast cancer: is there a link with oral contraceptives and hormone replacement therapy?
    Khoo SK; Chick P
    Med J Aust; 1992 Jan; 156(2):124-32. PubMed ID: 1736053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen replacement therapy and the risk of breast cancer: results from the case-control surveillance study.
    Kaufman DW; Palmer JR; de Mouzon J; Rosenberg L; Stolley PD; Warshauer ME; Zauber AG; Shapiro S
    Am J Epidemiol; 1991 Dec; 134(12):1375-85; discussion 1396-401. PubMed ID: 1663700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiologic aspects of exogenous progestagens in relation to their role in pathogenesis of human breast cancer.
    van Leeuwen FE
    Acta Endocrinol (Copenh); 1991; 125 Suppl 1():13-26. PubMed ID: 1801500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined effect of oral contraceptive use and hormone replacement therapy on breast cancer risk in postmenopausal women.
    Norman SA; Berlin JA; Weber AL; Strom BL; Daling JR; Weiss LK; Marchbanks PA; Bernstein L; Voigt LF; McDonald JA; Ursin G; Liff JM; Burkman RT; Malone KE; Simon MS; Folger SG; Deapen D; Wingo PA; Spirtas R
    Cancer Causes Control; 2003 Dec; 14(10):933-43. PubMed ID: 14750532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral contraceptives as related to cancer and benign lesions of the breast.
    Fasal E; Paffenbarger RS
    J Natl Cancer Inst; 1975 Oct; 55(4):767-73. PubMed ID: 1185801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The risk of breast cancer associated with oral contraception and hormone replacement therapy.
    Speroff L
    Womens Health Issues; 1992; 2(2):63-72; discussion 73-4. PubMed ID: 1535527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral contraceptives and the risk of breast cancer.
    Marchbanks PA; McDonald JA; Wilson HG; Folger SG; Mandel MG; Daling JR; Bernstein L; Malone KE; Ursin G; Strom BL; Norman SA; Wingo PA; Burkman RT; Berlin JA; Simon MS; Spirtas R; Weiss LK
    N Engl J Med; 2002 Jun; 346(26):2025-32. PubMed ID: 12087137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Female sex hormones increase the risk of breast cancer].
    Vatten L
    Tidsskr Nor Laegeforen; 1998 Aug; 118(19):2969-74. PubMed ID: 9748837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral contraceptives and breast cancer: review of the epidemiologic literature.
    Thomas DB
    Contraception; 1991 Jun; 43(6):597-642. PubMed ID: 1868735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral contraceptives and breast cancer risk among younger women.
    Brinton LA; Daling JR; Liff JM; Schoenberg JB; Malone KE; Stanford JL; Coates RJ; Gammon MD; Hanson L; Hoover RN
    J Natl Cancer Inst; 1995 Jun; 87(11):827-35. PubMed ID: 7791232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral contraceptives, menopausal hormone replacement treatment and breast cancer risk.
    Levi F; Lucchini F; Pasche C; La Vecchia C
    Eur J Cancer Prev; 1996 Aug; 5(4):259-66. PubMed ID: 8894563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Female hormone utilisation and risk of hepatocellular carcinoma.
    Tavani A; Negri E; Parazzini F; Franceschi S; La Vecchia C
    Br J Cancer; 1993 Mar; 67(3):635-7. PubMed ID: 8382515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral contraceptives and breast cancer risk in Taiwan, a country of low incidence of breast cancer and low use of oral contraceptives.
    Chie WC; Li CY; Huang CS; Chang KJ; Yen ML; Lin RS
    Int J Cancer; 1998 Jul; 77(2):219-23. PubMed ID: 9650556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral contraceptives and breast cancer.
    Jick H; Walker AM; Watkins RN; D'Ewart DC; Hunter JR; Danford A; Madsen S; Dinan BJ; Rothman KJ
    Am J Epidemiol; 1980 Nov; 112(5):577-85. PubMed ID: 7435486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contraception for the transitional years of women older than 40 years of age.
    Upton GV; Corbin A
    Clin Obstet Gynecol; 1992 Dec; 35(4):855-64. PubMed ID: 1451368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exogenous hormone use and the risk of postmenopausal breast cancer: results from The Netherlands Cohort Study.
    Schuurman AG; van den Brandt PA; Goldbohm RA
    Cancer Causes Control; 1995 Sep; 6(5):416-24. PubMed ID: 8547539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral contraceptive agents and breast cancer: a population-based case-control study.
    Rohan TE; McMichael AJ
    Med J Aust; 1988 Nov; 149(10):520-6. PubMed ID: 3185321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.